Current NDC auxiliary source row compounder:86

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 26436-0724
Product Ndc: 26436-0724
Product Ndc Digits: 264360724
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Naltrexone 2
Proprietary Name Suffix: [empty]
Nonproprietary Name: Naltrexone 2mg
Dosage Form Name: CAPSULE
Route Name: ORAL
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Hybrid Pharma
Establishment Name: Hybrid Pharma
Establishment Fei: [empty]
Substance Name: NALTREXONE
Active Ingredients Info: 2 mg
History Active Ingredients Raw: NALTREXONE
History Active Ingredients Info Raw: 2 mg
History Dosage Raw: CAPSULE
Dea Schedule: [empty]
Package Ndc Raw: 26436-0724-9
Package Ndc: 26436-0724-9
Package Ndc Digits: 2643607249
Package Ndc11: 26436072409
Package Description: 1 CAPSULE in 1 CAPSULE (26436-0724-9)
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:86
Source Row Number: 86
Source Row Hash: 62ae71d9e9f769e1f1c15d68fe8a54b7a2095f900cab9281b19b30525c7c1c47
Import Run Id: 20261013T114159Z
Loaded At: 2026-10-13 11:48:09

Exact raw FDA source fields#

{
    "ROUTENAME": "ORAL",
    "PRODUCTNDC": "26436-0724",
    "DEASCHEDULE": "",
    "LABELERNAME": "Hybrid Pharma",
    "SUBSTANCENAME": "NALTREXONE",
    "DOSAGEFORMNAME": "CAPSULE",
    "NDCPACKAGECODE": "26436-0724-9",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Naltrexone 2",
    "REPORTINGPERIOD": "2024-2",
    "NONPROPRIETARYNAME": "Naltrexone 2mg",
    "PACKAGEDESCRIPTION": "1 CAPSULE in 1 CAPSULE (26436-0724-9) ",
    "ACTIVEINGREDIENTSINFO": "2 mg",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:86
Source Row Number: 86
Status Scope: package
Lookup Ndc: 26436-0724-9
Lookup Ndc Digits: 2643607249
Product Ndc: 26436-0724
Product Ndc Digits: 264360724
Package Ndc: 26436-0724-9
Package Ndc Digits: 2643607249
Package Ndc11: 26436072409
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 62ae71d9e9f769e1f1c15d68fe8a54b7a2095f900cab9281b19b30525c7c1c47
Import Run Id: 20261013T114159Z
Loaded At: 2026-10-13 11:48:09